BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15677916)

  • 1. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 4. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2010 Jun; (6):CD000545. PubMed ID: 20556747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
    Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
    [No Abstract]   [Full Text] [Related]  

  • 12. Azathioprine-induce acute submandibular sialadenitis in a patient with Crohn's disease.
    Guerra Romero A; Pérez Calle JL; López Serrano P
    Gastroenterol Hepatol; 2018 Nov; 41(9):570-571. PubMed ID: 29150359
    [No Abstract]   [Full Text] [Related]  

  • 13. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
    Mardini HE
    Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
    Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
    Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Crohn's disease: the "long" of it.
    Hanauer SB; Thisted RA
    Gastroenterology; 2005 Jun; 128(7):2164-6. PubMed ID: 15940649
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term immunosuppressive treatment in Crohn's disease.
    Nyman M; Hansson I; Eriksson S
    Scand J Gastroenterol; 1985 Dec; 20(10):1197-203. PubMed ID: 3912958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease].
    Bastida Paz G; Nos Mateu P; Aguas Peris M; Beltrán Niclós B; Rodríguez Soler M; Ponce García J
    Gastroenterol Hepatol; 2007 Nov; 30(9):511-6. PubMed ID: 17980127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.
    Lennard-Jones JE
    Dig Dis Sci; 1981 Apr; 26(4):364-8. PubMed ID: 7016483
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
    Pearson DC; May GR; Fick GH; Sutherland LR
    Ann Intern Med; 1995 Jul; 123(2):132-42. PubMed ID: 7778826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.